Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Sayad Pierre Sargis exercised options for 20,679 Fennec Pharmaceuticals Inc. shares (Form 4)

Traded Mar 28 to Mar 31, 2026 · Filed Apr 2, 2026

From Mar 28 to Mar 31, 2026, Sayad Pierre Sargis (Chief Medical Officer) exercised options for 20,679 Fennec Pharmaceuticals Inc. shares, leaving 18,627 shares. Filed Apr 2, 2026 (Form 4).

Options exercised
20,679 shares
Holding after
18,627 shares
Trading plan
No
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 28, 2026Common sharesOption exercise2,05220,679Direct
Mar 31, 2026Common SharesOption exercise18,45618,456Direct
Mar 31, 2026Common sharesOption exercise17118,627Direct

Source

View original at SEC

Related